lncRNA-PRLB Confers Paclitaxel Resistance of Ovarian Cancer Cells by Regulating RSF1/NF-κB Signaling Pathway

Long noncoding RNA (lncRNA)-PRLB (progression-associated lncRNA in breast cancer) has been identified to enhance the drug resistance of breast cancer cells. In this study, the authors explored PRLB effect in the paclitaxel (Tax) resistance of ovarian cancer cells and revealed the role of RSF1 (remod...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Cancer biotherapy & radiopharmaceuticals 2021-03, Vol.36 (2), p.202-210
Hauptverfasser:	Zhao, Yuzi, Hong, Li
Format:	Artikel
Sprache:	eng
Schlagworte:	Apoptosis Binding sites Breast cancer Cell survival Drug resistance Flow cytometry Immunoprecipitation NF-κB protein Ovarian cancer Paclitaxel Polymerase chain reaction RNA-binding protein Signal transduction
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!